oncology medicine

Cordium Pharmaceuticals Pvt Ltd is a trusted pharmaceutical exporter and drop shipper from India, supplying Bosutinib Tablets 100MG, 400MG and 500MG to international markets. We support hospitals, pharmacies, pharmaceutical distributors and eligible patients with reliable sourcing and international shipping solutions. Bosutinib is an oral tyrosine kinase inhibitor (TKI) used in the treatment of Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML). Current prescribing information lists Bosutinib tablets in 100MG, 400MG and 500MG strengths. Bosutinib Tablets Available for Export Cordium Pharmaceuticals can arrange Bosutinib Tablets in the following strengths: Bosutinib 100MG Tablets Bosutinib 400MG Tablets Bosutinib 500MG Tablets Availability, manufacturer, packaging and quantities can be confirmed according to your requirement and applicable export regulations. Uses of Bosutinib Tablets Bosutinib is prescribed for eligible patients with Philadelphia chromosome-positive chronic myelogenous leukemia (Ph+ CML), including chronic-phase CML and, in appropriate patients, accelerated or blast-phase CML with resistance or intolerance to previous therapy. Treatment should be prescribed and monitored by a qualified healthcare professional. Bosutinib Dosage The appropriate Bosutinib dose depends on the patient's diagnosis, treatment history, response and medical condition. Current prescribing information specifies 400MG once daily with food for adults with newly diagnosed chronic-phase Ph+ CML, while 500MG once daily with food is used for adults with chronic, accelerated or blast-phase Ph+ CML who are resistant or intolerant to previous therapy. Do not select or change the strength or dosage without a doctor's prescription. Why Choose Cordium Pharmaceuticals? India-based pharmaceutical exporter and drop shipper Bosutinib 100MG/400MG/500MG sourcing Supply support for hospitals and pharmaceutical distributors International shipping assistance Professional export documentation support Competitive quotation based on quantity and destination Product sourcing from established pharmaceutical channels Dedicated support for international buyers Fast International Delivery from India Cordium Pharmaceuticals provides export and drop-shipping assistance for Bosutinib Tablets to eligible customers and businesses in: USA | UK | UAE | South Africa | Singapore | Australia | Canada | Germany | France Shipping time depends on destination, customs clearance, product availability and local import requirements. Buyers should verify applicable pharmaceutical import regulations before placing an order. Order Bosutinib Tablets from India Looking for a Bosutinib Tablets exporter in India? Contact Cordium Pharmaceuticals Pvt Ltd for product availability, strength, quantity, pricing and international shipping options. Request a Quote for Bosutinib 100MG / 400MG / 500MG Tablets today. Frequently Asked Questions 1. What is Bosutinib used for? Bosutinib is a kinase inhibitor used for specific forms of Philadelphia chromosome-positive chronic myelogenous leukemia (Ph+ CML). 2. Which Bosutinib strengths are available? Bosutinib tablets are available in 100MG, 400MG and 500MG strengths in current U.S. prescribing information. 3. Can I buy Bosutinib without a prescription? Bosutinib is a prescription medicine and should only be used under appropriate medical supervision. 4. Does Cordium Pharmaceuticals export Bosutinib from India? Yes. Cordium Pharmaceuticals Pvt Ltd provides pharmaceutical export and drop-shipping services from India, subject to product availability and destination-country regulations. 5. Do you ship Bosutinib internationally? International shipping support is available for eligible orders to countries including the USA, UK, UAE, South Africa, Singapore, Australia, Canada, Germany and France, subject to applicable import and customs requirements.

Leucovorin Calcium Tablets 15mg are supplied by Cordium Pharmaceuticals Pvt Ltd, a pharmaceutical exporter and dropshipping supplier based in India. We support international supply for hospitals, pharmacies, pharmaceutical distributors, healthcare businesses, and eligible personal-import requirements, subject to the destination country's regulations. Our export network supports fast international delivery from India to the USA, UK, UAE, South Africa, Singapore, Australia, Canada, Germany, and France, with appropriate documentation and shipping arrangements. Leucovorin Calcium Tablets 15mg – Product Overview Leucovorin calcium, also known as folinic acid, is a reduced form of folate used in specific medical treatment protocols. Leucovorin Calcium Tablets 15mg may be used under medical supervision for indications such as folate-related conditions and as part of certain chemotherapy-related treatment protocols. The appropriate strength, dosage, and duration depend on the patient's medical condition and the prescribing healthcare professional's instructions. Why Choose Cordium Pharmaceuticals Pvt Ltd? Cordium Pharmaceuticals Pvt Ltd provides reliable pharmaceutical export and dropshipping solutions from India, including: Leucovorin Calcium Tablets 15mg supply International pharmaceutical export support Fast shipping options to multiple countries Secure and professional packaging Assistance with export documentation Supply for hospitals, pharmacies, and pharma distributors Support for eligible personal-import orders Competitive international pricing Order-based dropshipping solutions International Supply & Fast Delivery We facilitate pharmaceutical shipments from India to: USA: New York, California, Texas, Florida, Washington and other locations UK: London, Manchester, Birmingham, Liverpool and other locations UAE: Dubai, Abu Dhabi, Sharjah, Ajman and other locations South Africa: Johannesburg, Cape Town, Durban and other locations Singapore, Australia, Canada, Germany and France Delivery times depend on destination, customs clearance, shipping service, product availability, and applicable import requirements. Leucovorin Calcium Tablets 15mg for Hospitals & Pharma Distributors Cordium Pharmaceuticals Pvt Ltd can support B2B pharmaceutical procurement for hospitals, pharmacies, distributors, clinics, and healthcare organizations. We can coordinate product availability, quantities, documentation, packaging, and international shipping according to the order requirements. For personal-import orders, customers should verify whether Leucovorin Calcium is permitted for import into their country and whether a valid prescription or import authorization is required. Storage & Handling Store Leucovorin Calcium Tablets according to the manufacturer's labeled storage conditions. Keep the medicine in its original packaging and protect it from unsuitable temperatures, moisture, and direct exposure as applicable. Order Leucovorin Calcium Tablets 15mg from India If you are looking for a Leucovorin Calcium Tablets 15mg exporter or dropshipping supplier in India, Cordium Pharmaceuticals Pvt Ltd can assist with international supply. Contact Cordium Pharmaceuticals Pvt Ltd for product availability, quotation, minimum order quantity, shipping options, and export documentation.

Cordium Pharmaceuticals Pvt Ltd is a trusted India-based pharmaceutical exporter and drop shipper supplying Letermovir Tablets 240MG and 480MG to hospitals, pharmacies, pharmaceutical distributors, healthcare organizations, and eligible international buyers. We provide export support to the USA, UK, UAE, South Africa, Singapore, Australia, Canada, and Germany, subject to applicable import regulations. Letermovir Tablets 240MG/480MG Letermovir is an antiviral medicine used to help prevent cytomegalovirus (CMV) infection and disease in certain high-risk transplant recipients. It works by inhibiting the CMV DNA terminase complex, an important component of viral replication. Letermovir tablets are available in 240MG and 480MG strengths. The appropriate strength and treatment duration depend on the patient's medical condition, transplant type, other medications, and healthcare professional's recommendation. Uses of Letermovir Tablets Letermovir may be prescribed for CMV prophylaxis in certain eligible patients, including: CMV-seropositive patients following allogeneic hematopoietic stem cell transplantation. Certain high-risk kidney transplant recipients. Patients requiring CMV prevention according to approved medical guidelines. Letermovir should be taken only according to a qualified healthcare professional's prescription. Letermovir Dosage The recommended dosage varies according to the patient's condition and concomitant medicines. In eligible adults, 480MG once daily is commonly used, while 240MG once daily may be appropriate in specific situations, including certain patients receiving cyclosporine. Patients should not change the dosage or stop treatment without consulting their doctor. Possible Side Effects Some patients may experience: Nausea Diarrhea Vomiting Headache Fatigue Cough Swelling or peripheral edema Letermovir can interact with several medicines. Patients should provide their doctor or pharmacist with a complete list of their current medicines before starting treatment. Letermovir Tablets Export from India Cordium Pharmaceuticals Pvt Ltd supports the international supply of Letermovir 240MG and 480MG Tablets from India. Our services are suitable for eligible hospitals, pharmacies, pharmaceutical distributors, and authorized importers. Export Destinations We provide pharmaceutical export assistance for: USA UK UAE South Africa Singapore Australia Canada Germany Fast shipping options may be available depending on product availability, destination, customs clearance, and local import requirements. Why Choose Cordium Pharmaceuticals? India-based pharmaceutical exporter and drop shipper Letermovir 240MG/480MG sourcing Competitive export pricing Support for bulk and institutional requirements Export documentation assistance International shipping coordination Supply to multiple global markets Professional order and customer support FAQs – Letermovir Tablets What are Letermovir Tablets used for? Letermovir is used to help prevent CMV infection and disease in certain eligible transplant recipients. What strengths of Letermovir are available? Letermovir tablets are available in 240MG and 480MG strengths. Can I source Letermovir from India? Eligible hospitals, distributors, pharmacies, and authorized importers can contact Cordium Pharmaceuticals for availability, pricing, and export requirements. Does Cordium Pharmaceuticals ship Letermovir internationally? Yes. We support pharmaceutical exports to the USA, UK, UAE, South Africa, Singapore, Australia, Canada, and Germany, subject to applicable regulations. Is Letermovir available for personal import? Personal import rules vary by country. Customers should verify prescription and import requirements with the relevant authorities before placing an order. Is Letermovir a prescription medicine? Yes. Letermovir should be used under appropriate medical supervision and according to the approved prescribing information. Request a Quote For Letermovir Tablets 240MG/480MG export from India, contact Cordium Pharmaceuticals Pvt Ltd for product availability, pricing, packaging, shipping options, and export documentation requirements. Important: Availability, importation, dispensing, and personal-import eligibility may differ between countries. Buyers should comply with all destination-country pharmaceutical and customs regulations.

Treosulfan Injection 5 g is an anticancer medicine containing treosulfan, an alkylating agent. Depending on the approved product and indication, treosulfan is used either in chemotherapy for certain cancers or as part of conditioning therapy before allogeneic hematopoietic stem-cell transplantation (alloHSCT). Key Highlights Active ingredient: Treosulfan Strength: 5 g per vial Dosage form: Powder for solution for infusion Route: Intravenous infusion Therapeutic class: Alkylating anticancer agent Prescription medicine: Yes Benefits and Uses of Treosulfan Injection Treosulfan works as a cytotoxic alkylating agent that damages the genetic material of target cells, helping prevent their growth and multiplication. Its approved use depends on the specific product and country. Treosulfan may be used: For advanced epithelial ovarian cancer after previous standard therapy in certain jurisdictions. As part of conditioning therapy before allogeneic stem-cell transplantation, in combination with medicines such as fludarabine. For conditioning regimens used in selected patients with hematological malignancies such as AML and MDS, according to applicable approvals. Dosage & Administration The dosage of Treosulfan Injection must be individualized by an oncologist or transplant specialist according to the indication, body-surface area, blood counts, organ function and treatment protocol. For some ovarian-cancer regimens, the product information specifies 5–8 g/m² for monotherapy, generally repeated every 3–4 weeks. For stem-cell-transplant conditioning, the FDA-approved GRAFAPEX regimen uses 10 g/m² once daily for three consecutive days, administered by intravenous infusion before stem-cell infusion. Treosulfan is supplied as a powder that must be properly reconstituted before intravenous administration by trained healthcare professionals. Do not self-administer this medicine or use the dosage stated above without medical supervision. Possible Side Effects Treosulfan can cause significant adverse effects, particularly suppression of blood-cell production. Common or important side effects may include: Low white blood cell and platelet counts Anemia Increased risk of infections Nausea and vomiting Diarrhea Mouth sores or mucositis Abdominal discomfort Fatigue Fever Swelling Skin reactions or rash Changes in liver or kidney laboratory values Severe or prolonged myelosuppression is an important safety concern, and blood counts require close monitoring during treatment. Seek urgent medical attention for fever, unusual bleeding or bruising, severe weakness, breathing difficulties, serious skin reactions, or signs of infection. Important Safety Information Treosulfan should only be administered under specialist medical supervision. Blood counts and other laboratory parameters should be monitored regularly. Patients should inform their healthcare provider about other medicines, previous chemotherapy or radiotherapy, pregnancy, breastfeeding, allergies, and existing medical conditions. Treosulfan may also affect fertility and pregnancy, and appropriate reproductive counselling may be required. Frequently Asked Questions 1. What is Treosulfan Injection 5 g used for? It is used in specific anticancer treatment and stem-cell-transplant conditioning protocols, depending on the product's approved indication. 2. How is Treosulfan 5 g administered? It is supplied as a powder that is reconstituted and administered intravenously by qualified healthcare professionals. 3. What is the usual dose of treosulfan? The dose varies considerably according to the indication and treatment protocol. For example, some ovarian-cancer regimens use 5–8 g/m², while the U.S. GRAFAPEX transplant-conditioning regimen uses 10 g/m² daily for three days. 4. Can Treosulfan be used without a prescription? No. Treosulfan is a prescription anticancer medicine requiring specialist supervision. 5. Does Treosulfan cause low blood counts? Yes. Myelosuppression is a major safety concern and can increase the risk of infection and bleeding. 6. Can Treosulfan be used during pregnancy? Treosulfan can pose risks to an unborn baby. Patients who are pregnant, planning pregnancy, or breastfeeding should discuss treatment with their specialist before administration. 7. Is Treosulfan 5 g suitable for every cancer patient? No. Its suitability depends on the cancer or transplant indication, treatment history, blood counts, overall health and the approved protocol. Medical information is for educational purposes only and does not replace the prescribing information or advice of a qualified healthcare professional.

Nivolumab Injection 40MG/100MG is a prescription immunotherapy medicine used in the treatment of several types of cancer. Nivolumab is a PD-1 immune checkpoint inhibitor that helps the immune system recognize and attack cancer cells. Nivolumab Injection 40MG/100MG Nivolumab is available as an intravenous injection in single-dose vials, including 40MG/4ML and 100MG/10ML presentations. It is administered by a qualified healthcare professional through an IV infusion. Benefits of Nivolumab Injection Nivolumab may provide the following therapeutic benefits when prescribed for an appropriate cancer indication: Helps activate the body's immune response against cancer cells. Blocks the PD-1 pathway used by cancer cells to evade immune attack. Can be used alone or in combination with other anticancer medicines depending on the cancer type. Used as part of treatment protocols for several advanced and, for certain cancers, earlier-stage malignancies. Uses of Nivolumab Injection Depending on the approved indication and patient's clinical condition, nivolumab may be used for cancers including: Melanoma Non-small cell lung cancer (NSCLC) Renal cell carcinoma Classical Hodgkin lymphoma Head and neck squamous cell carcinoma Urothelial carcinoma Hepatocellular carcinoma Esophageal cancer Gastric and gastroesophageal junction cancers Certain MSI-H/dMMR colorectal cancers Malignant pleural mesothelioma The exact approved indication can vary by country, cancer stage, biomarker status and combination therapy. Nivolumab Dosage & Administration Nivolumab dosage is individualized by an oncologist according to the cancer type, treatment regimen, age, clinical condition and whether it is being used alone or with other medicines. It is administered by intravenous infusion, generally in a hospital, cancer center or qualified medical facility. The infusion schedule varies according to the indication and treatment protocol. Important: Do not self-administer Nivolumab Injection or use a fixed dose without a specialist's prescription. Current prescribing information should always be followed because approved regimens can change. Nivolumab Side Effects Commonly reported adverse effects can include: Fatigue Rash or itching Diarrhea Nausea Musculoskeletal or joint pain Cough Reduced appetite Fever Headache Abdominal discomfort Nivolumab can also cause serious immune-mediated reactions affecting organs such as the lungs, liver, intestines, kidneys, skin and endocrine glands. Patients should promptly report unusual or severe symptoms to their healthcare provider. Important Safety Information Nivolumab treatment requires medical monitoring. Healthcare professionals may monitor liver enzymes, kidney function and thyroid function during treatment. Infusion-related reactions can also occur. Patients should inform their doctor about pregnancy, breastfeeding, existing medical conditions and all medicines they are taking. Nivolumab may cause fetal harm, and breastfeeding is not recommended during treatment and for the specified period after the final dose. Frequently Asked Questions 1. What is Nivolumab Injection used for? Nivolumab is an immunotherapy medicine used for several cancers, including melanoma, lung cancer, kidney cancer, Hodgkin lymphoma and other approved indications. 2. What are the available strengths of Nivolumab Injection? Common intravenous presentations include 40MG/4ML and 100MG/10ML single-dose vials. Other strengths may also be available depending on the market. 3. How is Nivolumab administered? It is administered intravenously by a healthcare professional, usually in a hospital or specialized medical facility. 4. How often is Nivolumab given? The treatment interval depends on the cancer type and prescribed regimen. The oncologist determines the appropriate schedule. 5. Can Nivolumab be combined with other medicines? Yes. Depending on the indication, nivolumab may be prescribed with medicines such as ipilimumab or chemotherapy. 6. Is Nivolumab chemotherapy? Nivolumab is immunotherapy, specifically a PD-1 immune checkpoint inhibitor. It works differently from traditional cytotoxic chemotherapy. 7. Can Nivolumab cause serious side effects? Yes. Immune-mediated adverse reactions can sometimes be severe or life-threatening and require prompt medical evaluation. 8. Who should prescribe Nivolumab? Nivolumab should be prescribed and administered under the supervision of a qualified oncologist or other appropriately trained healthcare professional. Medical Disclaimer: This page is for educational and SEO information only and does not replace professional medical advice, diagnosis or prescribing information. Nivolumab is a prescription cancer medicine and should be used only under appropriate medical supervision. Always consult the latest local prescribing information before treatment.

Vedolizumab Injection 300 mg is a prescription biologic medicine used to treat adults with moderately to severely active ulcerative colitis and Crohn’s disease. It works by targeting the α4β7 integrin pathway, helping reduce the movement of certain immune cells into inflamed intestinal tissue. Vedolizumab 300 mg Uses Vedolizumab may be prescribed for: Ulcerative colitis: Helps control intestinal inflammation and symptoms. Crohn’s disease: Helps reduce disease activity and support remission. Pouchitis: Approved for certain patients in some countries, including the UK. Treatment should be prescribed by a gastroenterologist or qualified healthcare professional. Benefits of Vedolizumab Potential benefits include: Helps reduce gastrointestinal inflammation Supports clinical response and remission May improve diarrhea and bowel urgency Provides a gut-selective mechanism of action Can be used as long-term maintenance therapy in suitable patients Vedolizumab 300 mg Dosage The usual adult IV schedule is: Week 0: 300 mg IV Week 2: 300 mg IV Week 6: 300 mg IV Maintenance: 300 mg every 8 weeks, when appropriate The infusion is generally administered over approximately 30 minutes by a healthcare professional. Some patients with reduced response may be considered for more frequent dosing under specialist supervision. Vedolizumab 300 mg Side Effects Common side effects may include: Headache Joint pain Nausea Fatigue Fever Nasopharyngitis Upper respiratory infections Cough Back pain Rash or itching Serious allergic or infusion reactions are possible. Patients should also report signs of infection or unusual neurological symptoms immediately. Important Precautions Before treatment, inform your doctor about: Active or recent infections Tuberculosis exposure or history Allergies Current medicines Previous biologic treatments Vaccination history Pregnancy or breastfeeding Vedolizumab should only be administered under appropriate medical supervision. Vedolizumab in USA, UK, UAE & South Africa USA: Used for appropriate adults with moderately to severely active ulcerative colitis and Crohn’s disease. UK: Used according to UK-approved prescribing information and specialist guidance. UAE: Patients should obtain Vedolizumab through authorized healthcare and pharmaceutical channels and follow local prescription and import requirements. South Africa: Supply and use should comply with local regulatory, prescribing and procurement requirements. Availability and approved indications can vary by country. FAQs What is Vedolizumab 300 mg used for? It is mainly used to treat moderately to severely active ulcerative colitis and Crohn’s disease in adults. How does Vedolizumab work? It blocks the α4β7 integrin pathway, reducing certain immune-cell movement into inflamed intestinal tissue. Is Vedolizumab chemotherapy? No. It is a targeted biologic monoclonal antibody. Is Vedolizumab a steroid? No. Vedolizumab is not a corticosteroid. How is Vedolizumab 300 mg given? It is administered by intravenous infusion by a healthcare professional. What are common side effects? Headache, joint pain, nausea, fatigue, fever and respiratory infections are among the commonly reported side effects. Can Vedolizumab cure Crohn’s disease? It is used to control Crohn’s disease and support remission but is not considered a guaranteed permanent cure. Can Vedolizumab be used for ulcerative colitis? Yes. It is an established biologic treatment option for appropriate adults with moderately to severely active ulcerative colitis. Conclusion Vedolizumab 300 mg Injection is an important biologic therapy for inflammatory bowel disease. With its targeted mechanism, it can help control inflammation and support remission in suitable patients with Crohn’s disease or ulcerative colitis.

Pertuzumab 420 mg/14 mL is a HER2-targeted monoclonal antibody used with other medicines for selected patients with HER2-positive breast cancer. It is commonly combined with trastuzumab and chemotherapy and is administered by intravenous infusion under specialist medical supervision. Cordium Pharmaceuticals Pvt Ltd is an India-based pharmaceutical exporter supporting international supply inquiries for eligible hospitals, pharmacies, distributors and authorized healthcare buyers. Pertuzumab 420 mg/14 mL Uses Pertuzumab may be used for: HER2-positive early breast cancer Selected breast cancer treatment before or after surgery HER2-positive metastatic breast cancer Certain locally recurrent, unresectable HER2-positive breast cancer HER2 status should be confirmed through appropriate diagnostic testing before treatment. Dosage & Administration A commonly used regimen consists of: Loading dose: 840 mg IV Maintenance dose: 420 mg every 3 weeks Pertuzumab 420 mg/14 mL is administered by intravenous infusion, not IV push or bolus. The exact dosage and treatment duration must be determined by an oncologist. Common Side Effects Possible side effects include: Diarrhea Nausea and vomiting Fatigue Hair loss Rash Muscle or joint pain Reduced appetite Low blood-cell counts Infusion reactions Pertuzumab may also affect heart function or cause serious allergic reactions, making appropriate medical monitoring important. Supply Locations Cordium Pharmaceuticals Pvt Ltd supports pharmaceutical export inquiries for eligible buyers in: USA: Washington, New York, California UAE: Dubai, Abu Dhabi UK: London, Manchester, Birmingham South Africa: Johannesburg, Cape Town, Durban Availability, prescription requirements, import permissions and product registration may vary by destination country. Why Choose Cordium Pharmaceuticals? India-based pharmaceutical exporter International supply and export coordination Support for hospitals, pharmacies and pharmaceutical distributors Experience with specialty and prescription medicines Export documentation assistance Professional shipping coordination Focus on quality-conscious pharmaceutical sourcing Support subject to destination-country regulations FAQs What is Pertuzumab 420 mg/14 mL used for? It is used with other medicines for selected patients with HER2-positive breast cancer. Is Pertuzumab chemotherapy? No. It is a targeted monoclonal antibody therapy that may be used alongside chemotherapy. How often is Pertuzumab given? A commonly used maintenance schedule is 420 mg every 3 weeks following an initial loading dose. How is Pertuzumab administered? It is given through intravenous infusion by qualified healthcare professionals. Can Pertuzumab affect the heart? Yes. Cardiac function may be affected, so doctors may perform heart monitoring during treatment. Can Cordium Pharmaceuticals export Pertuzumab? Cordium Pharmaceuticals Pvt Ltd supports international pharmaceutical supply inquiries, subject to product availability, prescriptions, import permissions and applicable regulations. Conclusion Pertuzumab 420 mg/14 mL is an important HER2-targeted medicine used in combination treatment for selected breast cancer patients. For international pharmaceutical sourcing from India, Cordium Pharmaceuticals Pvt Ltd provides export coordination for eligible healthcare and pharmaceutical buyers. Medical Disclaimer: This content is for educational purposes only. Pertuzumab is a prescription oncology medicine and should only be used under the supervision of a qualified oncologist.

Pertuzumab Injection 420 mg/14 mL is a targeted monoclonal antibody used with other cancer medicines for certain patients with HER2-positive breast cancer. It targets the HER2 receptor and helps interfere with signals involved in cancer-cell growth. Pertuzumab is administered by intravenous infusion under specialist medical supervision. What Is Pertuzumab 420 mg/14 mL? Pertuzumab is a HER2-targeted cancer therapy commonly used with trastuzumab and chemotherapy. The 420 mg/14 mL presentation is supplied as a concentrate for IV infusion and should be prepared and administered by trained healthcare professionals. Benefits of Pertuzumab Targets HER2-positive cancer cells. Used as part of combination treatment for breast cancer. May be used in selected early-stage HER2-positive breast cancer. Used for certain metastatic or locally recurrent breast cancers. Can be combined with trastuzumab and chemotherapy. May help reduce the risk of recurrence in appropriate patients. Uses of Pertuzumab Injection Pertuzumab may be prescribed for selected patients with: HER2-positive early breast cancer HER2-positive metastatic breast cancer Certain locally recurrent, unresectable HER2-positive breast cancer The appropriate treatment depends on HER2 status, cancer stage and the patient's overall health. Pertuzumab 420 mg/14 mL Dosage A commonly used adult regimen includes: Initial dose: 840 mg IV infusion Maintenance dose: 420 mg every 3 weeks The 420 mg/14 mL vial can provide the standard maintenance dose. Pertuzumab must be given by IV infusion, not IV push or bolus. The exact dosage and duration must be determined by an oncologist. Side Effects Common side effects may include: Diarrhea Nausea and vomiting Fatigue Hair loss Rash Reduced appetite Muscle or joint pain Low blood-cell counts Infusion-related reactions Serious Side Effects Pertuzumab can cause serious infusion or allergic reactions and may affect heart function. Patients should promptly report breathing difficulty, swelling, severe weakness, chest symptoms or other concerning reactions. Pertuzumab in USA, UK, UAE & South Africa Pertuzumab is used internationally for appropriate HER2-positive breast cancer treatment. Approved indications, availability and prescribing requirements can differ between the USA, UK, UAE and South Africa. Patients should obtain Pertuzumab through authorized healthcare providers and follow local regulatory requirements. FAQs What is Pertuzumab 420 mg/14 mL used for? It is used with other medicines to treat certain HER2-positive breast cancers. Is Pertuzumab chemotherapy? No. It is a targeted monoclonal antibody therapy that may be given with chemotherapy. How often is Pertuzumab given? A commonly used maintenance schedule is every 3 weeks after the initial loading dose. How is Pertuzumab administered? It is administered by intravenous infusion by qualified healthcare professionals. Can Pertuzumab affect the heart? Yes. Cardiac function may be affected, so monitoring can be required. Does Pertuzumab cause hair loss? Hair loss can occur, particularly when it is used with chemotherapy. Can Pertuzumab be used during pregnancy? Pertuzumab may cause fetal harm. Pregnancy-related risks should be discussed with a doctor before treatment. Conclusion Pertuzumab Injection 420 mg/14 mL is an important HER2-targeted therapy used in combination treatment for selected breast cancer patients. Proper dosage, administration and monitoring are essential, and treatment should always be supervised by a qualified oncologist. Medical Disclaimer: This page is for educational purposes only and does not replace professional medical advice. Always consult a qualified healthcare professional before using Pertuzumab.

Venetoclax is a prescription targeted cancer medicine used for certain blood cancers, especially chronic lymphocytic leukemia (CLL) and selected cases of acute myeloid leukemia (AML). It works by inhibiting the BCL-2 protein, helping cancer cells undergo programmed cell death. Important: Major regulatory references generally list Venetoclax 50 mg and 100 mg as oral tablets, rather than standard injections. Any product marketed as “Venetoclax Injection” should be verified for its formulation and regulatory status. Benefits of Venetoclax Targets the BCL-2 pathway. Helps destroy susceptible cancer cells. Used in selected CLL treatment regimens. Used with other medicines for certain AML patients. Provides a targeted treatment option for specific blood cancers. Uses CLL Venetoclax may be used alone or with other medicines such as obinutuzumab or rituximab, depending on the patient's treatment plan. AML For selected newly diagnosed AML patients who cannot undergo intensive chemotherapy, venetoclax may be combined with azacitidine or decitabine. Dosage Venetoclax dosage depends on the indication, treatment combination and patient's medical condition. In some CLL regimens, treatment begins with gradual dose escalation to reduce the risk of tumor lysis syndrome (TLS). A commonly used CLL escalation schedule is: 20 mg → 50 mg → 100 mg → 200 mg → 400 mg daily, with increases made over several weeks under medical supervision. Patients should never change the dose or treatment schedule without their oncologist's advice. How Venetoclax Works Venetoclax blocks BCL-2, a protein that helps certain cancer cells survive. Blocking BCL-2 can promote programmed death of susceptible malignant cells. Side Effects Possible side effects include: Low white blood cell count Anemia Low platelet count Infections Fever Nausea Diarrhea Fatigue Headache Constipation Serious complications can include tumor lysis syndrome and severe infections, requiring urgent medical attention. Safety Information Venetoclax may interact with several medicines, including certain antifungals, antibiotics and antivirals. Blood tests and other monitoring may be required during treatment. Patients should inform their healthcare provider about all medicines and supplements they are taking. Venetoclax in USA, UK, UAE & South Africa Venetoclax is a specialist prescription oncology medicine. Availability, approved uses, dosage forms and import requirements may differ across the USA, UK, UAE and South Africa. Hospitals, pharmacies and authorized pharmaceutical distributors should verify local regulations and product registration before procurement or importation. FAQs What is Venetoclax 50 mg/100 mg used for? It is used in selected treatment regimens for CLL and AML. Is Venetoclax an injection? Major regulatory references generally identify 50 mg and 100 mg strengths as oral tablets. Injectable products should be independently verified. Can Venetoclax be taken without a prescription? No. It should be used only under qualified medical supervision. Why is the dose increased gradually? Gradual dose escalation helps reduce the risk of tumor lysis syndrome. What are common side effects? Low blood counts, infections, nausea, diarrhea and fatigue are among the possible side effects. Who should prescribe Venetoclax? A qualified oncologist or hematologist should determine the appropriate treatment and dosage. Conclusion Venetoclax is an important targeted therapy for selected patients with CLL and AML. Because it can cause serious complications and interact with other medicines, treatment should always be supervised by a qualified healthcare professional. Medical Disclaimer: This page is for educational purposes only and does not replace professional medical advice or prescribing information.

Goserelin Injection 3.6 mg and 10.8 mg is a prescription GnRH agonist used to suppress sex-hormone production. It is commonly used in selected cases of prostate cancer, hormone-sensitive breast cancer, endometriosis and certain gynecological conditions. Benefits of Goserelin Injection Goserelin may: Reduce testosterone production in men. Suppress estrogen production in premenopausal women. Help control hormone-sensitive prostate cancer. Support treatment of certain hormone-sensitive breast cancers. Reduce symptoms associated with endometriosis. Help thin the uterine lining before selected procedures. Uses of Goserelin 3.6 mg/10.8 mg Prostate Cancer Goserelin reduces testosterone, helping control hormone-sensitive prostate cancer. The 10.8 mg formulation is commonly used as a long-acting treatment for approved prostate cancer indications. Breast Cancer Goserelin 3.6 mg may be used in suitable premenopausal or perimenopausal women with hormone-sensitive breast cancer. Endometriosis Goserelin 3.6 mg reduces ovarian hormone production and can help relieve endometriosis-related symptoms. Gynecological Conditions Depending on local approval, goserelin may also be used for selected uterine and reproductive-health indications. Goserelin Dosage Dosage must be determined by a healthcare professional. Goserelin 3.6 mg: commonly administered subcutaneously every 28 days. Goserelin 10.8 mg: commonly administered every 12 weeks for approved prostate cancer indications. Goserelin is administered as a depot implant under the skin of the lower abdomen. Side Effects of Goserelin Possible side effects include: Hot flashes and sweating Headache Fatigue Mood changes Reduced libido Sexual difficulties Vaginal dryness Menstrual changes Injection-site discomfort Bone-density loss with prolonged treatment In some men with prostate cancer, temporary worsening of symptoms can occur when treatment begins. Seek medical attention for severe or unusual symptoms. Precautions Tell your doctor if you have heart disease, diabetes, osteoporosis, urinary obstruction, spinal problems, allergies to GnRH medicines, or pregnancy-related concerns. Goserelin should be used only under medical supervision. Goserelin in USA, UK, UAE & South Africa Goserelin is used internationally, but approved indications, brands, strengths and availability can differ by country. Patients, hospitals, pharmacies and importers should follow local prescription and pharmaceutical regulations in the USA, UK, UAE and South Africa. FAQs What is Goserelin 3.6 mg used for? It may be used for prostate cancer, hormone-sensitive breast cancer, endometriosis and selected gynecological conditions. What is Goserelin 10.8 mg used for? It is primarily a long-acting hormonal treatment for approved prostate cancer indications. How often is Goserelin 3.6 mg given? It is commonly administered every 28 days. How often is Goserelin 10.8 mg given? For approved prostate cancer treatment, it is commonly administered every 12 weeks. Is Goserelin chemotherapy? No. Goserelin is a hormonal GnRH agonist, not conventional chemotherapy. Can Goserelin stop periods? Yes. Hormonal suppression may cause periods to stop during treatment. Who administers Goserelin? It should generally be administered by a qualified healthcare professional as a subcutaneous implant. Conclusion Goserelin 3.6 mg/10.8 mg Injection is an important hormonal therapy for selected hormone-sensitive cancers and gynecological conditions. The correct strength, dosage and treatment duration depend on the patient's condition and local prescribing information. Medical Disclaimer: This information is for educational purposes only and does not replace medical advice or official prescribing information.

Durvalumab Injection 50 mg/mL is a prescription immunotherapy used to treat certain cancers. It is a PD-L1 immune checkpoint inhibitor that helps the immune system recognize and attack cancer cells. It is administered by intravenous (IV) infusion under medical supervision. Benefits of Durvalumab Helps activate the immune response against cancer cells. Used for several approved cancer indications. May help control cancer progression. Can be used alone or with chemotherapy/other immunotherapy. Provides an established immunotherapy option for eligible patients. Uses Depending on local approvals, Durvalumab may be used for selected patients with: Non-small cell lung cancer (NSCLC) Small-cell lung cancer (SCLC) Biliary tract cancer Hepatocellular carcinoma Certain other approved cancers The appropriate use depends on the patient's diagnosis, cancer stage, previous treatment, and applicable guidelines. Dosage & Administration Durvalumab is given by intravenous infusion by trained healthcare professionals. For several adult indications, a commonly used regimen is 1,500 mg every 4 weeks for patients weighing at least 30 kg. Other dosing schedules may apply depending on the cancer and treatment combination. Patients should not change the dose or treatment schedule without their oncologist's advice. Common Side Effects Possible side effects include: Fatigue Cough Shortness of breath Rash Diarrhea Nausea Reduced appetite Muscle or joint pain Fever Infusion-related reactions Serious Side Effects Durvalumab may cause immune-related reactions affecting the lungs, liver, intestines, kidneys, thyroid, and other organs. Seek medical attention for severe breathing problems, persistent diarrhea, abdominal pain, jaundice, serious rash, unusual weakness, or other concerning symptoms. Durvalumab in USA, UK, UAE & South Africa Durvalumab is a prescription oncology medicine. Availability, approved indications, import requirements, and treatment guidelines can differ between the USA, UK, UAE, and South Africa. Hospitals, pharmacies, oncology centers, and healthcare providers should follow current local regulations and approved prescribing information. FAQs Is Durvalumab chemotherapy? No. It is an immunotherapy and PD-L1 inhibitor, although it may be combined with chemotherapy. How is Durvalumab administered? It is given through IV infusion by qualified healthcare professionals. What is the usual dose? A commonly used adult regimen for several indications is 1,500 mg every 4 weeks, but the dose depends on the specific cancer and treatment protocol. Can Durvalumab cause serious side effects? Yes. It can cause immune-related inflammation involving different organs and requires medical monitoring. Is Durvalumab available without a prescription? No. It is a prescription cancer medicine and should be used under specialist medical supervision. Medical Disclaimer This content is for general educational purposes only and does not replace professional medical advice. Durvalumab should only be prescribed and administered by qualified healthcare professionals.

Durvalumab Injection 120 mg/2.4 mL is an immunotherapy medicine containing durvalumab, a PD-L1 immune checkpoint inhibitor. It helps the immune system recognize and attack certain cancer cells. It is used for specific cancer indications based on local regulatory approvals in the USA, UK, UAE and South Africa. What Is Durvalumab 120 mg/2.4 mL? Durvalumab is a monoclonal antibody that blocks the PD-L1 pathway, helping immune cells maintain their ability to fight cancer. The 120 mg/2.4 mL presentation contains 120 mg of durvalumab in 2.4 mL and is administered by intravenous infusion. Benefits of Durvalumab Potential benefits when used for an approved indication include: Helps the immune system fight cancer cells Provides targeted immunotherapy Used in selected lung cancer treatment plans May be combined with chemotherapy or other anticancer medicines Can be used in different stages of cancer treatment depending on the indication Uses of Durvalumab Injection Depending on the approved indication, durvalumab may be used for: Non-small cell lung cancer (NSCLC) Small-cell lung cancer (SCLC) Biliary tract cancer Hepatocellular carcinoma Endometrial cancer Approved uses can vary between countries and patient populations. Durvalumab Dosage & Administration The dosage depends on the type of cancer, treatment regimen, body weight where applicable and other medicines being used. Durvalumab is administered through an intravenous infusion by a qualified healthcare professional. Patients should not change the prescribed dose or treatment schedule without medical supervision. Side Effects Commonly reported side effects may include: Fatigue Cough Diarrhea Rash or itching Nausea Decreased appetite Muscle or joint pain Shortness of breath Infusion-related reactions Durvalumab can also cause immune-related reactions affecting the lungs, liver, intestines, kidneys, skin and endocrine organs. Serious or unusual symptoms should be reported to a healthcare professional immediately. Durvalumab in USA, UK, UAE & South Africa Durvalumab is a prescription oncology medicine. Availability, approved indications, prescribing requirements and import regulations may differ in the USA, UK, UAE and South Africa. Hospitals, oncology centers, pharmacies and distributors should follow applicable local regulations. FAQs What is Durvalumab 120 mg/2.4 mL used for? It is an immunotherapy used for selected cancer indications, including certain lung cancers and other approved cancers. Is Durvalumab chemotherapy? No. Durvalumab is an immunotherapy, although it may be used together with chemotherapy in certain treatment protocols. How is Durvalumab given? It is administered by intravenous infusion by trained healthcare professionals. How often is Durvalumab administered? The treatment schedule depends on the cancer type and prescribed treatment regimen. Can Durvalumab cause serious side effects? Yes. Immune-mediated reactions can sometimes be serious. Medical monitoring is important during treatment. Can Durvalumab be used during pregnancy? Durvalumab may pose risks to an unborn baby. Pregnancy and breastfeeding should be discussed with the treating healthcare professional. Who should prescribe Durvalumab? Durvalumab should be prescribed and monitored by a qualified oncologist or other appropriate specialist. Key Product Details Product: Durvalumab Injection Strength: 120 mg/2.4 mL Active Ingredient: Durvalumab Class: PD-L1 Immune Checkpoint Inhibitor Route: Intravenous infusion Use: Selected cancer indications Medical Disclaimer: This page provides general educational information and does not replace professional medical advice. Durvalumab is a prescription medicine, and its dosage and use should be determined by a qualified healthcare professional.